Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 5, No 6 (2009) STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? Abstract  similar documents
I. N. Grigorieva, Y. M. Pozdnyakov
"... Results of combined therapy of gallstone disease (GSD), non-alcoholic fatty liver disease (NAFLD ..."
 
Vol 12, No 4 (2016) Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk Abstract  similar documents
O. M. Drapkina, O. N. Korneeva
"... The problem of non-alcoholic fatty liver disease (NAFLD), which is an independent risk factor ..."
 
Vol 13, No 5 (2017) NON-ALCOHOLIC FATTY LIVER DISEASE AND CARDIOVASCULAR RISK: SCIENTIFIC PROBLEM STATE Abstract  similar documents
O. M. Drapkina, A. A. Yafarova
"... Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, which ..."
 
Vol 9, No 2 (2013) STATIN SAFETY REVISITED DATA Abstract  similar documents
O. M. Drapkina
"... fatty liver disease, viral hepatitis C are considered separately. ..."
 
Vol 13, No 1 (2017) SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION Abstract  similar documents
S. N. Bel'diev
"... and nonalcoholic fatty liver disease (NAFLD) or other hepatobiliary diseases, especially in cases when elevated ..."
 
Vol 4, No 4 (2008) CHOICE OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC LIVER DISEASES Abstract  similar documents
M. N. Mamedov, O. M. Drapkina
"... A number of comorbid patients is increasing significantly. Chronic diffusive liver diseases meet ..."
 
Vol 11, No 2 (2015) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT? Abstract  similar documents
S. Yu. Martsevich, O. V. Lerman, N. P. Kutishenko, A. Yu. Suvorov
"... with cardiovascular diseases and concomitant chronic liver diseases. Material and methods. Сross-sectional ..."
 
Vol 11, No 5 (2015) The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis Abstract  similar documents
S. A. Smetnev, A. N. Meshkov
"... Currently, cardiovascular diseases (CVD) remain the main problem in the world and in Russia ..."
 
Vol 12, No 6 (2016) CURRENT METHODS OF ENDOTHELIAL DYSFUNCTION ASSESSMENT AND THEIR POSSIBLE USE IN THE PRACTICAL MEDICINE Abstract  similar documents
A. V. Shabrov, A. G. Apresyan, A. L. Dobkes, S. U. Ermolov, T. V. Ermolova, S. G. Manasyan, S. V. Serdyukov
"... factors of many different diseases. Such assessments can be useful in everyday medical practice ..."
 
Vol 7, No 5 (2011) DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. V. Perova, V. A. Metel'skaya, E. I. Sokolov, G. N. Shchukina, V. M. Fomina
"... The world publications data about the impact of consumption and the fatty acids ratio in consumed ..."
 
Vol 12, No 3 (2016) THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? Abstract  PDF (Eng)  similar documents
S. N. Bel'diev
"... to use statins in patients with cardiovascular diseases and concomitant chronic liver diseases. Analysis ..."
 
Vol 4, No 3 (2008) OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION Abstract  similar documents
A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk
"... Aim. To estimate an efficacy of therapy with ω-3 polyunsaturated fatty acids (PUFA) in patients ..."
 
Vol 15, No 2 (2019) Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics Abstract  similar documents
G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov
"... polyunsaturated fatty acid can be used in the dosage of 2-4 g daily. In patients with triglyceride level higher ..."
 
Vol 9, No 3 (2013) PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY Abstract  similar documents
S. A. Rumyantseva, R. G. Oganov, V. A. Stupin, E. V. Silina, A. S. Orlova, S. B. Bolevich, V. V. Afanasev, E. N. Kabaeva, S. A. Volik
"... Disorders of intermediary metabolism in the glycolysis cycles and fatty acids oxidation play ..."
 
Vol 10, No 1 (2014) MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) Abstract  PDF (Eng)  similar documents
A. M. Kalinina
"... of subjects who have died of ischemic heart disease (IHD) undiagnosed during life-time. To estimate ..."
 
Vol 10, No 6 (2014) VALIDATION OF THE MACNEW QUESTIONNAIRE FOR THE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ISHEMIC HEART DISEASE Abstract  PDF (Eng)  similar documents
N. V. Pogosova, A. A. Kursakov, I. H. Boycharov, S. Höfer, N. Oldridge
"... ) in both global and Russian practice. In many countries HRQL in patients with ischemic heart disease (IHD ..."
 
Vol 13, No 3 (2017) ROLE OF PULMONARY HYPERTENSION IN THE DEVELOPMENT OF CIRRHOTIC CARDIOMYOPATHY Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... Aim. To investigate the presence of pulmonary hypertension (PH) in patients with viral liver ..."
 
Vol 15, No 2 (2019) Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... of antiviral therapy on these parameters in patients with viral liver cirrhosis (VLC). Material and methods ..."
 
Vol 15, No 3 (2019) Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... with CVH were examined, the average age was 41 years, the disease duration – 3.6 years. The patients were ..."
 
Vol 8, No 2 (2012) CLINICAL IMPLICATION OF FATTY ACID CHANGES IN PATIENTS WITH PRIMARY GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION Abstract  similar documents
N. N. Kushnarenko, A. V. Govorin
"... Aim. To study blood levels of non-esterified fatty acids (NEFAs) and adenyl nucleotides, and fatty ..."
 
Vol 12, No 6 (2016) EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... in patients with chronic viral hepatitis (CVH) and viral liver cirrhosis (VLC). Material and methods. Doppler ..."
 
Vol 14, No 3 (2018) FEATURES OF HEART LESIONS IN PATIENTS WITH VIRAL LIVER CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin
"... of antiviral therapy on certain cardiohemodynamic parameters in patients with viral liver cirrhosis (VLC ..."
 
Vol 14, No 4 (2018) Some Morpho-Functional Changes of the Left Heart in Patients with Viral Liver Cirrhosis Abstract  similar documents
M V. Chistyakova, A. V. Govorin, N. N. Kushnarenko
"... . The average age of patients 42 years, disease duration – 3,8 years. Depending on the presence of ascites ..."
 
Vol 9, No 1 (2013) THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS Abstract  similar documents
A. O. Malygin, V. L. Doshchitsin
"... Antiarrhythmic effect of omega-3 polyunsaturated fatty acids (ω-3 PUFA), eicosapentaenoic ..."
 
Vol 8, No 1 (2012) OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
"... For today there are convincing evidences of beneficial effect of ω-3 polyunsaturated fatty acids ..."
 
Vol 10, No 5 (2014) EFFICACY OF ROSUVASTATIN IN DYSLIPIDEMIA CORRECTION IN PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION Abstract  similar documents
R. D. Kurbanov, N. U. Zakirov, Y. G. Kevorkova, N. B. Sayfiddinova
"... cholesterol target levels by the end of the third month of treatment in 91% of patients. Elevated liver ..."
 
Vol 13, No 2 (2017) ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE Abstract  similar documents
V. I. Podzolkov, N. A. Dragomiretskaya
"... , spironolactone, chronic heart failure, hypertension, liver cirrhosis. For citation: Podzolkov V ..."
 
Vol 8, No 3 (2012) THE EFFICACY OF COMBINED BIOMARKER TESTS IN EARLY DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION AFTER CLINICAL SYMPTOMS ONSET: ROLE OF HEART-TYPE FATTY ACID-BINDING PROTEIN Abstract  similar documents
O. V. Baturina, S. R. Gilyarevsky, I. M. Kuzmina, M. A. Godkov, E. V. Klychnikova
"... Aim. To evaluate the diagnostic value of heart-type fatty acid-binding protein (H-FABP ..."
 
Vol 8, No 2 (2012) THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya
"... A comparison of ivabradine and omega-3 polyunsaturated fatty acids, drugs with principally ..."
 
Vol 2, No 3 (2006) NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION Abstract  similar documents
A. I. Martinov, V. L. Chomenko
"... fatty acids (PUFAs) were analyzed. It was proved that PUFAs class omega-3 have positive effects ..."
 
Vol 10, No 2 (2014) STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov
"... for all patients because of liver diseases and/or biliary tract. Some of the patients with high treatment ..."
 
Vol 11, No 3 (2015) THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) Abstract  similar documents
N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov
"... . The UDCA intake was recommended to all the patients due to the presence of liver and/or bile duct diseases ..."
 
Vol 12, No 6 (2016) POSSIBLE CHANGES IN THE CENTRAL HEMODYNAMICS IN PORTAL HYPERTENSION DUE TO LIVER CIRRHOSIS OF VIRAL ETIOLOGY WITH DIFFERENT LEVELS OF CYTOKINES Abstract  similar documents
V. E Kulikov, T. A. Emelina, O. G. Kazakova, K. V. Nikolaevа, M. E. Hapman, M. A. Tonеeva
"... hemodynamics in liver cirrhosis classes A, B, C (Child– Pugh) to improve the early diagnostics of extrahepatic ..."
 
Vol 13, No 4 (2017) FEATURES OF CEREBRAL HEMODYNAMICS AND MANIFESTATIONS OF HEPATIC ENCEPHALOPATHY IN CIRRHOSIS OF VIRAL ETIOLOGY AT DIFFERENT COMPENSATION STAGES WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION Abstract  similar documents
V. E. Kulikov, T. A. Emelina, O. G. Kazakova, K. V. Nikolaevа, M. E. Hapman, M. A. Tonеeva
"... stage of cirrhosis compensation. Keywords: cirrhosis of liver, interleukin-2, interleukin-6, tumor ..."
 
Vol 14, No 4 (2018) Hepatotoxicity of New Oral Anticoagulants Abstract  similar documents
A. R. Kasimova, A. V. Philippova (Guryanova), A. S. Kolbin
"... of various manifestations of liver damage in the use of the new oral anticoagulants (NOAC) for the registered ..."
 
Vol 9, No 3 (2013) STATINS AND RISK OF INFECTIOUS DISEASES Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
"... , and pneumonia particularly. Results of the large studies on statin influence on infectious disease are presented. ..."
 
Vol 10, No 1 (2014) ARTERIAL STIFFNESS AND CHRONIC KIDNEY DISEASE: CAUSES AND CONSEQUENCES Abstract  similar documents
J. D. Kobalava, Yu. V. Kotovskaya, S. V. Villevalde, A. E. Soloveva, I. M. Amirbegishvili
"... Chronic kidney disease (CKD) is associated with increased cardiovascular risk. CKD ..."
 
Vol 5, No 4 (2009) COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS Abstract  PDF (Eng)  similar documents
N. A. Karoli, A. P. Rebrov
"... Aim. To study prevalence and features of cardiovascular diseases (arterial hypertension, ischemic ..."
 
Vol 6, No 4 (2010) HYPOANDROGEN CONDITION AND CARDIOVASCULAR DISEASES: ACTUAL QUESTIONS OF COMORBIDITY IN CLINICAL PRACTICE Abstract  similar documents
G. G. Sharvadze, D. G. Kurbatov, E. A. Poddubskaya, M. N. Mamedov
"... diseases and finally to improve quality of life and life expectancy of these patients. ..."
 
Vol 11, No 5 (2015) Excess winter cardiovascular morbidity in Ivanovo Region in 2009-2013 years Abstract  similar documents
A. V. Kontsevaya, J. A. Balanova, M. M. Loukianov, M. B. Khudyakov, O. A. Belova, S. V. Romanchuk
"... Chronic non-infectious diseases are characterized by irregular morbidity and mortality throughout ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... dysfunction at the pre-dialysis stage of the disease in order to reduce the risk of progression of chronic ..."
 
Vol 15, No 2 (2019) Detectability of Subclinical Hypothyroidism and Thyroid Stimulating Hormone Levels Associated with Cardiovascular Diseases in Patients of North-West Region Hospital Abstract  similar documents
A. R. Volkova, O. D. Dygun, O. N. Zhdanova, B. G. Lukichev, L. A. Belyakova, E. M. Sereda
"... with cardiovascular diseases (CVD) is an important clinical task. Aim. To study the detectability of subclinical ..."
 
Vol 15, No 3 (2019) Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases Abstract  similar documents
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina
"... with the prevalence and mortality from cardiovascular diseases (CVD). The presence of BAC on mammograms is associated ..."
 
Vol 11, No 6 (2015) Alcohol consumption in patients with cardiovascular diseases (results of the survey of cardiac patients in outpatient practice) Abstract  similar documents
O. D. Ostroumova, I. E. Nikolaeva, S. Ya. Eregin, I. V. Pokrovskaya, K. A. Ishchenko
"... diseases and to determine their preferences regarding the help in limiting alcohol consumption. Material ..."
 
Vol 8, No 3 (2012) THE PROBLEM OF THE OPTIMAL PHARMACOTHERAPY CHOICE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina
"... disease is discussed. Expert’s opinions are presented concerning first-line antiischemic drugs and about ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES Abstract  similar documents
A. N. Meshkov
"... of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors ..."
 
Vol 7, No 6 (2011) DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova
"... hypertension (HT) and chronic ischemic heart disease (CIHD), and to establish their significance and hierarchy ..."
 
Vol 5, No 3 (2009) RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov
"... ) and/or coronary heart disease (CHD) as well as to study risk factors of erectile dysfunction. Material ..."
 
Vol 6, No 1 (2010) THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
"... diseases (arterial hypertension, ischemic heart disease, chronic heart failure, rhythm disorders ..."
 
Vol 4, No 4 (2008) BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST Abstract  similar documents
L. N. Malaj
"... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..."
 
Vol 13, No 3 (2017) ISCHEMIC HEART DISEASE AND RENAL DYSFUNCTION Abstract  similar documents
F. I. Belyalov
"... The ischemic heart disease (IHD) with comorbid kidney dysfunction has more severe course and worse ..."
 
Vol 14, No 2 (2018) DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT Abstract  similar documents
N. В. Perepech, A. V. Tregubov
"... for primary and secondary prevention of cardiovascular diseases. 276 questionnaires filled out by 185 ..."
 
Vol 11, No 2 (2015) CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION Abstract  similar documents
V. N. Shishkova
"... The question of mutual influence of risk factors for cardiovascular and renal diseases ..."
 
Vol 10, No 4 (2014) MODERN PRINCIPLES OF QUALITY ASSESSMENT OF CARDIOVASCULAR DISEASES TREATMENT Abstract  similar documents
A. Yu. Suvorov, S. Yu. Martsevich
"... The most common ways of assessment of cardiovascular diseases treatment abroad, approaches ..."
 
Vol 10, No 1 (2014) MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT Abstract  similar documents
E. I. Trisvetova
"... Progression of cardiovascular disease is often caused by a deficiency of magnesium in the human ..."
 
Vol 9, No 6 (2013) DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. D. Deev, S. A. Boytsov
"... At the present time ischemic heart disease (IHD) continues to be the leading cause ..."
 
Vol 10, No 3 (2014) ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Abstract  similar documents
E. I. Leonova, G. G. Shehan, V. S. Zadionchenko, K. M. Bogatyrova
"... disease are discussed. The impact of chronic obstructive pulmonary disease treatment on the onset ..."
 
Vol 9, No 1 (2013) CHARACTERISTICS OF THE TYPES OF LEFT VENTRICULAR REMODELING AMONG WORKING AGE MEN WITH ISCHEMIC HEART DISEASE, LIVING IN ONE OF THE MOUNTAIN REGIONS OF AZERBAIJAN Abstract  similar documents
N. R. Ismaylova, F. A. Kuliev, A. F. Zeynalov
"... types in ischemic heart disease (IHD) among men of working age in one of the mountain regions ..."
 
Vol 1, No 1 (2005) NITRATES IN ISCHEMIC HEART DISEASE TREATMENT, YESTERDAY AND TODAY Abstract  similar documents
S. N. Tereschenko, N. A. Djaiani, E. V. Iljina
"... The problem of nitrate formulation choice in treatment of patients with ischemic heart disease ..."
 
Vol 1, No 1 (2005) ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES Abstract  similar documents
Y. A. Karpov
"... of the role of ACE inhibitors in treatment of patients with stable form of ischemic heart disease without ..."
 
Vol 3, No 1 (2007) DIZZINESS OF ISCHEMIC GENESIS: DESCRIPTION OF VESTIBULAR DISORDERS AND POSSIBILITY OF THERAPY Abstract  similar documents
N. S. Alekseeva
"... with mild dizziness in initial and reversible cerebrovascular emdiseases/em and estimate the efficacy ..."
 
Vol 8, No 3 (2012) CARDIOPROTECTIVE EFFECT OF PHYSICAL REHABILITATION IN PATIENTS WITH ISCHEMIC-ORIGIN DIASTOLIC DYSFUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
N. P. Lyamina, A. N. Nosenko, I. B. Razborova, O. V. Orlikova, E. V. Kotel'nikova, E. S. Karpova
"... on diastolic function, depending on the degree of recanalization, in patients with ischemic heart emdisease/em (ICD ..."
 
Vol 11, No 6 (2015) Nephrogenic factors of resistance to antihypertensive treatment in patients with essential hypertension Abstract  similar documents
N. V. Teplova, V. A. Lyusov, R. G. Oganov, E. M. Evsikov, R. A. Sharipov, M. H. Zhapoeva, E. G. Kurumlidu
"... Медика; 2005: 95-116). 14. Mukhin NA, Fomin VV. Arterial hypertension in chronic kidney emdisease/em ..."
 
Vol 3, No 3 (2007) DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS (PART I) Abstract  similar documents
Y. A. Vasyuk, A. V. Lebedev
"... mechanisms connecting depression and ischemic heart emdisease/em (IHD) are given. Influence of concomitant ..."
 
Vol 8, No 4 (2012) THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
L. E. Chekuldaeva, S. V. Obuhova, A. A. Simakov, L. V. Poljaeva, E. I. Rjazanova
"... heart emdisease/em (IHD, stable angina; n=55) were included into the study. Patients were randomized ..."
 
Vol 8, No 4 (2012) UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina
"... cardiovascular emdiseases/em is one of the priorities of modern medicine. This therapy usually consists of several ..."
 
Vol 3, No 4 (2007) DEPRESSION, ANXIETY AND MYOCARDIAL INFARCTION: EVERYTHING JUST BEGINS. PART II Abstract  similar documents
Y. A. Vasyuk, A. V. Lebedev
"... in myocardial infarction, pathophysiological mechanisms connecting depression and ischemic heart emdisease/em (IHD ..."
 
Vol 3, No 4 (2007) EFFECT OF BRONCHODILATORS ON HEART RATE VARIABILITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Abstract  similar documents
H. H. Shugushev, M. V. Gurizeva, V. M. Vasilenko
"... in patients with chronic obstructive pulmonary emdisease/em (COPD). Material and methods. 144 patients with COPD ..."
 
Vol 6, No 4 (2010) CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE Abstract  similar documents
O. I. Afanasieva, M. V. Ezhov, M. I. Afanasieva, M. S. Safarova, J. V. Berestetskaya, S. N. Pokrovsky
"... Background. Atherosclerosis is a systemic emdisease/em. That is why the damage is not restricted by one ..."
 
Vol 5, No 1 (2009) CARDIOLOGICAL MANAGEMENT OF PREGNANT WOMEN IN THE UDMURT REPUBLIC Abstract  similar documents
I. R. Gaisin, R. M. Valeeva, L. V. Shilina, N. Yu. Chernisheva, N. I. Maksimov
"... emdiseases/em (CVD) in the Udmurt Republic (UR) of Russia. Material and methods. In prospective ..."
 
Vol 8, No 5 (2012) ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? Abstract  similar documents
S. A. Boldueva, I. A. Leonova
"... and the main indications are discussed. ASA use for primary cardiovascular emdiseases/em prevention and its possible ..."
 
Vol 5, No 1 (2009) ECHOCARDIOGRAPHIC AND LABORATORY MARKERS OF CHRONIC HEART FAILURE: WHETHER IT IS POSSIBLE TO USE THEM IN RHEUMATIC MITRAL DISEASES? Abstract  similar documents
T. A. Kazakovtseva, N. A. Shostak
"... ) natriuretic peptides, in patients with mitral heart emdiseases/em of rheumatic aetiology. Material and methods ..."
 
Vol 6, No 5 (2010) THE USE OF ATORVASTATIN FOR THE PREVENTION OF RECURRENT ATRIAL FIBRILLATION AFTER ELECTRICAL CARDIOVERSION IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tereshchenko, N. G. Chuich, A. L. Syrkin, D. A. Andreev, A. V. Kolchurina, V. P. Terentev, A. Yu. Borozinets
"... electrical cardioversion in patients with ischemic heart emdisease/em (IHD) and paroxysmal AF. Material ..."
 
Vol 6, No 5 (2010) PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE Abstract  similar documents
M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva
"... of ED in the majority of men (about 80% of patients) is cardiovascular emdiseases/em (atherosclerosis ..."
 
Vol 5, No 2 (2009) DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov
"... which treat and follow-up patients with cardiovascular emdiseases/em (CVD). Material and methods ..."
 
Vol 7, No 4 (2011) METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE Abstract  similar documents
M. S. Berezhnova
"... of cardiovascular emdisease/em. There are a lot of approaches to drop smoking including innovative pharmacotherapy ..."
 
Vol 5, No 3 (2009) ARTERIAL HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS Abstract  similar documents
N. M. Nikitina, A. P. Rebrov
"... - emDisease/em Activity Score; **- p0,01 Таблица 2. Частота встречаемости АГ в зависимости от степени ..."
 
Vol 6, No 1 (2010) AMLODIPINE IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON ANTIATHEROSCLEROTIC PROPERTIES Abstract  similar documents
Yu. M. Lopatin
"... , amlodipine, in patients with coronary artery emdisease/em. Results of randomized clinical trials PREVENT (2000 ..."
 
Vol 6, No 1 (2010) EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS Abstract  PDF (Eng)  similar documents
D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova
"... therapy in patients with ischemic heart emdisease/em (IHD) after acute coronary events in real practice ..."
 
Vol 2, No 4 (2006) EFFECTS OF ENALAPRIL ON ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
L. I. Katelnizkaya, L. A. Chaischeva
"... Aim. To study endothelium vasomotor function (EF) in patients with ischemic heart emdisease/em (IHD ..."
 
Vol 4, No 5 (2008) EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE Abstract  similar documents
S. N. Tolpygina, S. Y. Martsevich
"... with stable course of ischemic heart emdisease/em (IHD). Material and methods. 50 patients (34 men and 16 women ..."
 
Vol 12, No 3 (2016) REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko
"... of various cardiovascular emdiseases/em (CVD) were among participants of the meeting. The importance of modern ..."
 
Vol 12, No 5 (2016) The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies Abstract  similar documents
E. K. Butina, E. V. Bochkareva
"... Measures for the prevention of cardiovascular emdiseases/em (CVD) are more effective ..."
 
Vol 12, No 6 (2016) THE PREVALENCE OF ELECTROCARDIOGRAPHIC INDICATORS AMONG MEN AND WOMEN OF OLDER AGES IN THE RUSSIAN FEDERATION Abstract  similar documents
G. A. Muromtseva, A. D. Deev, V. V. Konstantinov, A. A. Shalnova, S. A. Boytsov
"... . Keywords: prevalence of ischemic heart emdisease/em, Minnesota code, electrocardiography. 712 Rational ..."
 
Vol 13, No 1 (2017) AGOMELATINE IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
N. Yu. Shimohina, M. M. Petrova, A. A. Savchenko, M. S. Chernyaeva
"... of depression in patients with ischemic heart  emdisease/em (IHD) and to the possibilities of antidepressant therapy ..."
 
Vol 13, No 1 (2017) THE LINK BETWEEN VITAMIN В12 DEFICIENCY, RISK OF CARDIOVASCULAR DISEASES AND AGING PROCESS Abstract  similar documents
O. M. Drapkina, R. N. Shepel
"... emdiseases/em. Usually internists consider that vitamin В12 deficiency is associated with disturbances ..."
 
Vol 13, No 5 (2017) COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES Abstract  similar documents
A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash
"... Background. The problem of comorbidity in ischemic heart emdisease/em (IHD) has always been given ..."
 
Vol 13, No 6 (2017) FACTORS INFLUENCING ON THE MORTALITY IN PATIENTS WITH OBLITERATING DISEASES OF LOWER LIMB ARTERIES Abstract  similar documents
A. N. Sumin, M. A. Kosova, Ju. D. Medvedeva, A. V. Shcheglova, O. I. Rajh, S. A. Makarov, G. V. Artamonova, L. S. Barbarash
"... emdiseases/em of the lower extremities arteries at the stage of outpatient observation. Material and methods ..."
 
Vol 13, No 6 (2017) SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis Abstract  similar documents
O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina
"... heart emdisease/em (IHD); cerebral circulation disorders; lower respiratory tract infection; chronic ..."
 
Vol 14, No 1 (2018) SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking Abstract  similar documents
O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva
"... quitting smoking the ischemic heart emdisease/em (IHD) risk will be 2 folds lower than the risk in smoking ..."
 
Vol 14, No 3 (2018) CAROTID ARTERY STENTING IN A PATIENT WITH SINUS BRADYCARDIA: CLINICAL CASE Abstract  similar documents
E. S. Bulgakova, T. V. Tvorogova, B. A. Rudenko, O. M. Drapkina
 
Vol 14, No 5 (2018) Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... and concomitant emdiseases/em in the patients under study, and also to evaluate the usefulness of the diagnostic ..."
 
Vol 9, No 3 (2013) ALGORITHM FOR MANAGEMENT OF HYPERTENSIVE PATIENTS UNDERWENT UROLOGY INTERVENTIONS Abstract  similar documents
S. S. Davydova
"... complications in the early postop- erative period. Key words: arterial hypertension, ischemic heart emdisease/em ..."
 
Vol 3, No 1 (2007) THE CAPABILITIES OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN CLINICAL PRACTICE: FOCUS ON VASOPROTECTION Abstract  similar documents
D. B. Nebieridze, A. S. Safaryan
"... demonstrate the efficacy of ACE inhibitors in slowing down of emdisease/em progression related to atherosclerosis ..."
 
Vol 7, No 6 (2011) CURRENT APPROACHES TO EVALUATION OF THE MULTIVESSEL CORONARY ATHEROSCLEROSIS IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
D. N. Perutsky, I. B. Kovalenko, S. L. Konstantinov, T. I. Makeeva, M. V. Filatov
"... evaluation of the multivessel coronary atherosclerosis in patients with chronic ischemic heart emdisease/em D ..."
 
Vol 12, No 1 (2016) Effect of magnesium on the cardiovascular system in women Abstract  PDF (Eng)  similar documents
E. A. Ulubieva, A. G. Avtandilov
"... blood cells) levels and increased risk of somatic emdiseases/em in women of reproductive age. Hypomagnesemia ..."
 
Vol 11, No 4 (2015) THE ATTITUDE TOWARDS TREATMENT OF CARDIOVASCULAR DISEASES: A SURVEY OF PATIENTS OF STATE OUTPATIENT CLINICS AND PRIVATE MEDICAL CENTERS Abstract  similar documents
O. N. Semenova, E. A. Naumova, Yu. G. Shvarts
"... Aim. To study the differences in views on treatment among patients with cardiovascular emdiseases/em ..."
 
Vol 14, No 3 (2018) APPROACHES TO THE CHOICE OF ANTICOAGULANT THERAPY IN THE TREATMENT OF PATIENTS WITH COMBINATION OF ATRIAL FIBRILLATION WITH CORONARY HEART DISEASE OR PERIPHERAL ATHEROSCLEROSIS: POTENTIAL OF APIXABAN Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, I. Yu. Orlova, E. A. Smolyarchuk, J. S. Pavlova
"... emdiseases/em – coronary heart emdisease/em (CHD), including acute coronary syndrome (ACS) in history, peripheral ..."
 
Vol 15, No 1 (2019) Factors Associated with Cause-Specific Death in Russia. Data from Longitudinal Prospective Study 1977-2001 Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. V. Kapustina, A. D. Deev, Yu. A. Balanova
"... and their associations with cause-specific mortalities: coronary heart emdisease/em (CHD), stroke, cardiovascular emdiseases/em ..."
 
Vol 15, No 2 (2019) E.I. Chazov and His Role in the Development of the Epidemiology of Cardiovascular Diseases Abstract  similar documents
article Editorial
 
1 - 100 of 270 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)